MLNT Target Hit - Can It Carry On IN The trend?

Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Morristown, NJ.

SHORT INTEREST
1.05M 08/30/19

P/E Current
-0.18

P/E Ratio (with extraordinary items)
-0.27

Average Recommendation: HOLD

Average Target Price: 12.00